Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial.
.
Item in Clipboard
Ann N Y Acad Sci. 2021 Sep 8. doi: 10.1111/nyas.14681. Online ahead of print. Ann N Y Acad Sci. 2021. PMID: 34498278 . N Engl J Med. 2021 Sep 8:NEJMoa2110362. doi: 10.1056/NEJMoa2110362. Online ahead of print. N Engl J Med. 2021. PMID: 34496194 . Brief Bioinform. 2021 Sep 2;22(5):bbaa427. doi: 10.1093/bib/bbaa427. Brief Bioinform. 2021. PMID: 33515024 .